USE OF GONADOTROPIN-RELEASING HORMONE AGONISTS IN TREATMENT OF RECURRENT PRE-MENSTRUAL ENDOMETRIAL HYPERPLASIA
This article presents modern insights into the pathogenesis of endometrium hyperplastic processes, matrix metalloproteinases and their tissue inhibitors, and their role in development of endometrium hyperplasia. A pathogenetic substantiation is given for use of Lucrin Depot, which affects the key mo...
Saved in:
Main Authors: | Yu. E. Dobrokhotova, L. V. Saprykina, N. A. Litvinova, Yu. N. Zadonskay |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2016-09-01
|
Series: | Акушерство, гинекология и репродукция |
Subjects: | |
Online Access: | https://www.gynecology.su/jour/article/view/265 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HORMONAL AND ENERGETIC CHANGES IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL CANCER
by: A. L. Chernyshova, et al.
Published: (2016-02-01) -
Prognostic value of microcirculatory changes and alterations in the cellular microenvironment in patients with glandular hyperplasia of the endometrium and endometrial cancer (literature review)
by: Yu. S. Korneva, et al.
Published: (2019-07-01) -
Role of steroid hormones, estrogen receptors and metabolites in the development of endometrial hyperplasia and carcinoma
by: A. L. Chernyshova, et al.
Published: (2012-12-01) -
Endometrial markers of polycystic ovary syndrome (literature review)
by: E. M. Sharifulin, et al.
Published: (2017-09-01) -
CELL MOTILITY PROTEINS IN ENDOMETRIUM CARCINOMA AND ENDOMETRIAL HYPERPLASIA: ASSOCIATION WITH CANCER RISK
by: N. V. Yunusova, et al.
Published: (2020-10-01)